Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Science Advances
|
January 7, 2026
Linear ubiquitination triggers Amph-mediated T-tubule biogenesis
Kohei Kawaguchi, Yutaro Hama, Harunori Yoshikawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2021
Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition
Mayuko Akiu, Takashi Tsuji, Yoshitaka Sogawa, et al.
Cancer Science
|
April 19, 2016
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy
Yoshiaki Kawano, Wataru Takahashi, Masatoshi Eto, et al.
The Journal of Urology
|
August 27, 2015
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer
Akira Yokomizo, Yusuke Kanimoto, Takehiko Okamura, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2021
Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators
Anthony B Pinkerton, E Hampton Sessions, Paul Hershberger, et al.
Bioorganic & Medicinal Chemistry
|
June 10, 2014
Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P₁ agonists
Takashi Tsuji, Keisuke Suzuki, Tsuyoshi Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma
Noriyuki Ito, Masatoshi Eto, Eijiro Nakamura, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2012
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist
Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, et al.
Genes & Genetic Systems
|
June 21, 2021
Spatiogenetic characterization of S receptor kinase (SRK) alleles in naturalized populations of Raphanus sativus L. var. raphanistroides on Yakushima island
Kazuki Fukushima, Toko Kanomata, Aoi Kon, et al.
European Journal of Medicinal Chemistry
|
March 13, 2012
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist
Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Science Advances
|
January 7, 2026
Linear ubiquitination triggers Amph-mediated T-tubule biogenesis
Kohei Kawaguchi, Yutaro Hama, Harunori Yoshikawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 22, 2021
Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition
Mayuko Akiu, Takashi Tsuji, Yoshitaka Sogawa, et al.
Cancer Science
|
April 19, 2016
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy
Yoshiaki Kawano, Wataru Takahashi, Masatoshi Eto, et al.
The Journal of Urology
|
August 27, 2015
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer
Akira Yokomizo, Yusuke Kanimoto, Takehiko Okamura, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 2, 2021
Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators
Anthony B Pinkerton, E Hampton Sessions, Paul Hershberger, et al.
Bioorganic & Medicinal Chemistry
|
June 10, 2014
Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P₁ agonists
Takashi Tsuji, Keisuke Suzuki, Tsuyoshi Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2007
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma
Noriyuki Ito, Masatoshi Eto, Eijiro Nakamura, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2012
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist
Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, et al.
Genes & Genetic Systems
|
June 21, 2021
Spatiogenetic characterization of S receptor kinase (SRK) alleles in naturalized populations of Raphanus sativus L. var. raphanistroides on Yakushima island
Kazuki Fukushima, Toko Kanomata, Aoi Kon, et al.
European Journal of Medicinal Chemistry
|
March 13, 2012
Synthesis and evaluation of CS-2100, a potent, orally active and S1P(3)- sparing S1P(1) agonist
Tsuyoshi Nakamura, Masayoshi Asano, Yukiko Sekiguchi, et al.
Page
of 6